Sara Di Giulio

10PUBLICATIONS
12CO-AUTHORS
AllergyCancer therapy (excl. chemotherapy and radiation therapy)Epidemiological modellingPainGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jul 25, 2026
JAK Inhibitor Safety in Atopic Dermatitis and Alopecia Areata: A 4.5-Year Real-World Retrospective Cohort Study.

|Jul 03, 2026
Comparative Effectiveness and Safety of Baricitinib and Ritlecitinib in Severe Alopecia Areata: A Real-World Monocentric Retrospective Study.

|Mar 17, 2026
Short-Term Effectiveness and Safety of Deucravacitinib in Psoriasis: A Multicenter Real-World Study with Scalp-Specific Outcomes-IL PSO (Italian Landscape Psoriasis).

Luciano Ibba, Sara Di Giulio, Piergiorgio Malagoli

|Oct 29, 2025
Real-Life Effectiveness and Safety of Bimekizumab in Plaque Psoriasis Involving Difficult-to-Treat Areas: A 52-Week, Retrospective Real-World, Single-Center Study.

Matteo Bianco, Francesco D'Oria, Gioele Ghezzi

|Sep 27, 2025
Predictors of Super-Responder Status to Anti-IL-23 Therapies in Moderate-to-Severe Plaque Psoriasis: A Real-World Monocenter Study.

Sara Di Giulio, Costanza Falcidia, Giulio Foggi

|May 14, 2025
Real-World Effectiveness and Safety of Upadacitinib and Abrocitinib in Moderate-to-Severe Atopic Dermatitis: A 52-Week Retrospective Study.

Luciano Ibba, Costanza Falcidia, Sara Di Giulio

Pageof 2

Frequent Collaborators

9 joint publications

Luigi Gargiulo

7 joint publications

Luciano Ibba

6 joint publications

Mario Valenti

5 joint publications

Matteo Bianco